 |
 |
15th Conference on Retroviruses and Opportunistic Infections
Boston, MA
February 3-8, 2008
|
|
New Hope for Treatment Experienced
February 11, 2008
At the 15th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, David Evans talks with UCLA researcher, David Hardy, MD, about the latest data on antiretroviral options for people who are heavily treatment experienced and learns that the treatment landscape has changed radically.
10 minutes. Click here to view the transcript.
NEW! Scroll down to comment on this story.
Previous Comments:
comments 1 - 1 (of 1 total)
Murph, Port Townsend, WA, 2008-02-13 14:22:11
This is such exciting news for those of us who are treatment experienced and resistant to most or all of the existing meds. The feeling of being near the "end of the line" is a scary burden that wears over time, and this sends us a lot of hope. Thanks for sharing the news, POZ!
comments 1 - 1 (of 1 total)
Our general CROI conference coverage was sponsored by Abbott Laboratories, Boehringer Ingelheim and Gilead Sciences.
Additional funding, to support news and video coverage of women's issues at CROI, was provided by Tibotec Therapeutics.
|
|
|
More from CROI 2008
Starting and Switching Treatment
HIV/AIDS Complications and Treatment Side Effects
Experimental HIV Drugs
HIV Transmission and Prevention
Expert Interviews
|
|
